V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280004928 | 280003274 | 1.7 | 167 | Palliative (P) | 2014-03-06 | 2014-03-06 | CARBOPLATIN + RT | N | N | 280028204 | CARBOPLATIN + RT |
| 280004929 | 280003275 | 0 | 75.9 | Curative (C) | 2016-12-25 | 2017-01-06 | STS Rhabdomyosarco RMS 2005 IVADoVV | 01 | null | 280028205 | NOT MATCHED |
| 280004930 | 280007689 | 1.7 | null | Curative (C) | null | 2016-06-14 | Carboplatin AUC 2 - 5 | N | Y | 280028207 | CARBOPLATIN |
| 280004931 | 280007689 | 0 | 94.8 | Curative (C) | 2015-04-28 | 2015-04-28 | Trial Unspecified | N | N | 280028207 | TRIAL |
| 280004932 | 280003276 | 1.68 | 104 | Curative (C) | 2014-09-06 | 2014-09-09 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 280028210 | CISPLATIN + GEMCITABINE |
| 280004933 | 280003276 | 1.61 | 55.1 | Palliative (P) | 2015-10-04 | 2015-10-07 | EW EuroEwing 2012 Arm B IE | N | N | 280028210 | TRIAL |
| 280004934 | 280003276 | 1.88 | null | Curative (C) | 2015-08-05 | 2015-08-11 | Cetuximab 7 day (Cycle 1) | 1 | N | 280028210 | CETUXIMAB |
| 280004935 | 280003276 | 1.54 | 62.2 | Curative (C) | 2013-10-25 | 2013-10-25 | CISPLATIN + GEMCITABINE | Y | null | 280028210 | CISPLATIN + GEMCITABINE |
| 280004936 | 280011582 | 1.6 | 71.5 | Not known (9) | 2018-08-23 | 2018-08-23 | FLUOROURACIL + IRINOTECAN | 02 | N | 280028214 | LANREOTIDE |
| 280004937 | 280003277 | null | 65 | Palliative (P) | null | 2017-04-09 | CARBOPLATIN + PACLITAXEL + RT | N | null | 280028217 | OXALIPLATIN + MDG |
| 280004938 | 280003277 | null | null | Palliative (P) | null | 2017-01-23 | LANREOTIDE | null | null | 280028217 | IPILIMUMAB |
| 280004939 | 280003278 | 1.57 | null | Adjuvant (A) | 2013-06-19 | 2013-07-10 | DE-ESCALATE TRIAL | N | N | 280028221 | MITOMYCIN INTRAVESICULAR |
| 280004940 | 280003278 | 1.94 | 0 | null | 2016-11-10 | 2016-11-12 | VIDE | N | null | 280028221 | BEVACIZUMAB + CAPE + IRINOTECAN |
| 280004941 | 280003278 | 1.76 | null | Palliative (P) | 2013-03-04 | 2013-03-05 | STS Rhabdomyosarcoma RMS 2005 IVA | null | N | 280028221 | CAPECITABINE + STREPTOZOCIN |
| 280004942 | 280003278 | 1.6 | 88.4 | Palliative (P) | 2014-08-12 | 2014-08-12 | Doxorubicin + Olaratumab | Y | N | 280028221 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN |
| 280004943 | 280003278 | 1.62 | 92.2 | null | 2013-06-19 | 2013-06-19 | DE-ESCALATE TRIAL | null | null | 280028221 | GEMCARBO |
| 280004944 | 280003278 | 1.6 | 66.1 | null | 2013-09-24 | 2013-09-24 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 280028221 | LANREOTIDE |
| 280004945 | 280003279 | null | 71.2 | Palliative (P) | 2015-08-31 | 2016-11-13 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | 280028229 | OXALIPLATIN + MDG |
| 280004946 | 280003279 | 0 | 85.4 | Palliative (P) | 2017-06-24 | 2017-07-08 | Cetuximab +Cisplatin + FU (Cycle 1) | 2 | N | 280028229 | OXALIPLATIN + MDG |
| 280004947 | 280003279 | 2 | 114 | Palliative (P) | 2017-12-10 | 2017-12-28 | LANREOTIDE | 02 | N | 280028229 | OXALIPLATIN + MDG |
| 280004948 | 280003279 | 1.6 | 77.7 | Not known (9) | null | 2015-06-25 | LANREOTIDE | N | N | 280028229 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 280004949 | 280003280 | 1.6 | 70 | null | null | 2018-02-13 | CYCLOPHOSPHAMIDE | null | null | 280028236 | GEMCARBO |
| 280004950 | 280003280 | 1.6 | 68.1 | Palliative (P) | 2013-08-25 | 2013-08-26 | LIPOSOMAL DOXORUBICIN | 02 | N | 280028236 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 280004951 | 280003280 | 1.63 | null | Palliative (P) | 2014-02-07 | 2014-02-07 | OCTREOTIDE | 02 | N | 280028236 | IRINOTECAN + MDG |
| 280004952 | 280011031 | null | 107 | Palliative (P) | 2019-04-08 | 2019-04-24 | LIPOSOMAL DOXORUBICIN | null | N | 280028241 | CISPLATIN + ETOPOSIDE |
| 280004953 | 280011031 | 1.76 | 75 | Palliative (P) | 2016-10-09 | 2016-10-29 | Capecitabine + Cisplatin | N | null | 280028241 | ECARBOX |
| 280004954 | 280003281 | 1.87 | 90 | Palliative (P) | 2017-08-09 | 2017-08-15 | Carboplatin + Liposomal Doxorubicin | N | N | 280028243 | GEMCITABINE |
| 280004955 | 280003282 | null | 88 | null | null | 2017-12-20 | Docetaxel + Gemcitabine with GCSF | N | N | 280028248 | GEMCARBO |
| 280004956 | 280003283 | 1.83 | 81 | Palliative (P) | 2017-08-01 | 2017-08-04 | CHOP R - 21 days | 02 | N | 280028253 | IPILIMUMAB |
| 280004957 | 280003283 | 1.88 | 70.6 | Palliative (P) | 2018-11-29 | 2018-12-04 | Capecitabine | N | N | 280028253 | MITOMYCIN INTRAVESICULAR |
| 280004958 | 280003284 | 1.8 | 63.25 | Palliative (P) | 2013-11-14 | 2013-11-15 | LANREOTIDE | Y | Y | 280028255 | ECX |
| 280004959 | 280007696 | 1.63 | 70.1 | Neo-adjuvant (N) | 2015-02-28 | 2015-03-04 | STS Rhabdomyosarcoma RMS 2005 IVADo | 01 | N | 280028256 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 280004960 | 280003285 | 1.78 | 79.9 | Neo-adjuvant (N) | null | 2014-02-19 | LANREOTIDE | null | null | 280028259 | BEVACIZUMAB |
| 280004961 | 280003286 | null | null | Curative (C) | 2016-10-04 | 2016-10-04 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 280028261 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + ETOPOSIDE + VINCRISTINE |
| 280004962 | 280003287 | 0.83 | null | Palliative (P) | null | 2018-03-06 | Gemcitabine weekly | N | N | 280028262 | ECX |
| 280004963 | 280003288 | 1.74 | 77.9 | Palliative (P) | 2013-10-09 | 2013-10-10 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 280028266 | CAPECITABINE + OXALIPLATIN |
| 280004964 | 280003288 | null | 67.2 | null | 2016-07-10 | 2016-07-10 | Paclitaxel 7 day | N | N | 280028266 | PANTHER TRIAL |
| 280004965 | 280003288 | 1.74 | 72.1 | Palliative (P) | 2017-05-31 | 2017-05-31 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280028266 | ECX |
| 280004966 | 280003289 | null | null | Palliative (P) | null | 2017-10-04 | Oxaliplatin + Modified de Gramont | null | null | 280028271 | ECX |
| 280004967 | 280003289 | 1.62 | 71 | Palliative (P) | 2013-03-21 | 2013-03-21 | Cyclophosphamide oral | N | N | 280028271 | CAPECITABINE + OXALIPLATIN |
| 280004968 | 280003290 | null | null | Palliative (P) | 2016-03-13 | 2016-04-08 | Paclitaxel 7 day | N | null | 280028275 | CARBOPLATIN + VINORELBINE |
| 280004969 | 280003290 | 1.7 | 60.8 | Neo-adjuvant (N) | 2013-06-05 | 2013-06-19 | Bevacizumab + Cape + Oxali 21day | N | N | 280028275 | ECX |
| 280004970 | 280003290 | 1.63 | 0 | Curative (C) | 2017-03-14 | 2017-03-15 | Cisplatin + Pemetrexed | N | N | 280028275 | MITOMYCIN INTRAVESICULAR |
| 280004971 | 280003290 | 1.69 | 8.9 | Disease modification (D) | 2016-12-16 | 2016-12-29 | Paclitaxel 7 day | 2 | N | 280028275 | IRINOTECAN + MDG |
| 280004972 | 280003291 | 1.82 | 112.2 | Palliative (P) | 2013-12-23 | 2013-12-26 | Irinotecan + Modified De Gramont | 02 | N | 280028279 | CAV |
| 280004973 | 280003291 | 0 | 76.9 | Palliative (P) | 2014-10-25 | 2014-10-26 | Cisplatin + Etoposide (3 day) | Y | N | 280028279 | GEMCARBO |
| 280004974 | 280003291 | 1.52 | null | Palliative (P) | null | 2014-12-21 | BCG Intravesical | null | null | 280028279 | VEMURAFENIB |
| 280004975 | 280003292 | 1.82 | 75.3 | Palliative (P) | 2017-05-19 | 2017-05-19 | Carboplatin + Pemetrexed | 02 | N | 280028286 | GEMCARBO |
| 280004976 | 280003292 | 1.79 | 90 | Palliative (P) | 2014-12-09 | 2014-12-16 | Liposomal Doxorubicin (Caelyx) | N | N | 280028286 | VEMURAFENIB |
| 280004977 | 280003292 | 1.71 | 69.35 | Palliative (P) | 2014-07-17 | 2014-08-05 | Liposomal Doxorubicin (Caelyx) | N | N | 280028286 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |